Pitcairn Co. increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 3,725 shares of the company’s stock after purchasing an additional 197 shares during the quarter. Pitcairn Co.’s holdings in HCA Healthcare were worth $1,118,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other hedge funds have also bought and sold shares of the business. MML Investors Services LLC raised its holdings in shares of HCA Healthcare by 31.7% during the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares during the last quarter. Meritage Group LP bought a new position in shares of HCA Healthcare during the 3rd quarter valued at $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in HCA Healthcare during the fourth quarter valued at $18,044,000. NRI Wealth Management LC purchased a new position in HCA Healthcare in the fourth quarter worth about $2,896,000. Finally, Czech National Bank increased its position in shares of HCA Healthcare by 4.5% during the 4th quarter. Czech National Bank now owns 39,543 shares of the company’s stock valued at $11,869,000 after purchasing an additional 1,691 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.
Insider Buying and Selling
In related news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the completion of the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at approximately $4,971,757.08. This trade represents a 38.22 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.30% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
View Our Latest Analysis on HCA Healthcare
HCA Healthcare Trading Down 4.8 %
Shares of HCA opened at $332.53 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The stock has a market capitalization of $81.87 billion, a PE ratio of 15.14, a P/E/G ratio of 1.10 and a beta of 1.68. The company’s fifty day moving average is $327.23 and its 200 day moving average is $339.87. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.
HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the company earned $5.90 earnings per share. Sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.
HCA Healthcare Increases Dividend
The company also recently announced a quarterly dividend, which was paid on Monday, March 31st. Stockholders of record on Monday, March 17th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date was Monday, March 17th. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio (DPR) is 13.11%.
About HCA Healthcare
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
Featured Articles
- Five stocks we like better than HCA Healthcare
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What is the Nikkei 225 index?
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- How to Use the MarketBeat Stock Screener
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.